194 related articles for article (PubMed ID: 32540198)
1. Performance of Lung Nodule Management Algorithms for Lung-RADS Category 4 Lesions.
Gupta S; Jacobson FL; Kong CY; Hammer MM
Acad Radiol; 2021 Aug; 28(8):1037-1042. PubMed ID: 32540198
[TBL] [Abstract][Full Text] [Related]
2. The effect of a novel Bayesian penalised likelihood PET reconstruction algorithm on the assessment of malignancy risk in solitary pulmonary nodules according to the British Thoracic Society guidelines.
Murphy DJ; Royle L; Chalampalakis Z; Alves L; Martins N; Bassett P; Breen R; Nair A; Bille A; Chicklore S; Cook GJ; Subesinghe M
Eur J Radiol; 2019 Aug; 117():149-155. PubMed ID: 31307640
[TBL] [Abstract][Full Text] [Related]
3. Assessment of indeterminate pulmonary nodules detected in lung cancer screening: Diagnostic accuracy of FDG PET/CT.
Garcia-Velloso MJ; Bastarrika G; de-Torres JP; Lozano MD; Sanchez-Salcedo P; Sancho L; Nuñez-Cordoba JM; Campo A; Alcaide AB; Torre W; Richter JA; Zulueta JJ
Lung Cancer; 2016 Jul; 97():81-6. PubMed ID: 27237032
[TBL] [Abstract][Full Text] [Related]
4. Risk of malignancy in pulmonary nodules: A validation study of four prediction models.
Al-Ameri A; Malhotra P; Thygesen H; Plant PK; Vaidyanathan S; Karthik S; Scarsbrook A; Callister ME
Lung Cancer; 2015 Jul; 89(1):27-30. PubMed ID: 25864782
[TBL] [Abstract][Full Text] [Related]
5.
Taralli S; Scolozzi V; Foti M; Ricciardi S; Forcione AR; Cardillo G; Calcagni ML
Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):429-436. PubMed ID: 30535767
[TBL] [Abstract][Full Text] [Related]
6. Cancer Risk in Subsolid Nodules in the National Lung Screening Trial.
Hammer MM; Palazzo LL; Kong CY; Hunsaker AR
Radiology; 2019 Nov; 293(2):441-448. PubMed ID: 31526256
[TBL] [Abstract][Full Text] [Related]
7. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.
Horeweg N; van Rosmalen J; Heuvelmans MA; van der Aalst CM; Vliegenthart R; Scholten ET; ten Haaf K; Nackaerts K; Lammers JW; Weenink C; Groen HJ; van Ooijen P; de Jong PA; de Bock GH; Mali W; de Koning HJ; Oudkerk M
Lancet Oncol; 2014 Nov; 15(12):1332-41. PubMed ID: 25282285
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Fluorodeoxyglucose F18-Labeled Positron Emission Tomography for Diagnosis of High-Risk Lung Nodules.
Maiga AW; Deppen SA; Mercaldo SF; Blume JD; Montgomery C; Vaszar LT; Williamson C; Isbell JM; Rickman OB; Pinkerman R; Lambright ES; Nesbitt JC; Grogan EL
JAMA Surg; 2018 Apr; 153(4):329-334. PubMed ID: 29117314
[TBL] [Abstract][Full Text] [Related]
9. Multi-observer concordance and accuracy of the British Thoracic Society scale and other visual assessment qualitative criteria for solid pulmonary nodule assessment using FDG PET-CT.
Fatania K; Brown PJ; Xie C; McDermott G; Callister MEJ; Graham R; Subesinghe M; Gleeson FV; Scarsbrook AF
Clin Radiol; 2020 Nov; 75(11):878.e21-878.e28. PubMed ID: 32709393
[TBL] [Abstract][Full Text] [Related]
10. Rate of benign nodule resection in a lung cancer screening program.
El Alam R; Byrne SC; Hammer MM
Clin Imaging; 2023 Dec; 104():109984. PubMed ID: 37832324
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Performance of the Herder Model in Veterans Undergoing PET Scans for Pulmonary Nodule Evaluation.
Vayntrub Y; Gartman E; Nici L; Jankowich MD
Lung; 2021 Dec; 199(6):653-657. PubMed ID: 34787695
[TBL] [Abstract][Full Text] [Related]
12. Interobserver agreement of the visual Herder scale for the assessment of solitary pulmonary nodules on 18F Fluorodeoxyglucose PET/computed tomography.
Ordidge KL; Gandy N; Arshad MA; Wallitt K; Soneji N; Khan S; Barwick TD
Nucl Med Commun; 2020 Mar; 41(3):235-240. PubMed ID: 31923048
[TBL] [Abstract][Full Text] [Related]
13. Evaluation and Management of Indeterminate Pulmonary Nodules on Chest Computed Tomography in Asymptomatic Subjects: The Principles of Nodule Guidelines.
Nam JG; Goo JM
Semin Respir Crit Care Med; 2022 Dec; 43(6):851-861. PubMed ID: 35803268
[TBL] [Abstract][Full Text] [Related]
14. Vancouver Risk Calculator Compared with ACR Lung-RADS in Predicting Malignancy: Analysis of the National Lung Screening Trial.
White CS; Dharaiya E; Dalal S; Chen R; Haramati LB
Radiology; 2019 Apr; 291(1):205-211. PubMed ID: 30667335
[TBL] [Abstract][Full Text] [Related]
15. Cost-Effectiveness of Treatment Thresholds for Subsolid Pulmonary Nodules in CT Lung Cancer Screening.
Hammer MM; Eckel AL; Palazzo LL; Kong CY
Radiology; 2021 Sep; 300(3):586-593. PubMed ID: 34128723
[TBL] [Abstract][Full Text] [Related]
16. Detecting Pulmonary Nodules in Lung Cancer Patients Using Whole Body FDG PET/CT, High-resolution Lung Reformat of FDG PET/CT, or Diagnostic Breath Hold Chest CT.
Flavell RR; Behr SC; Mabray MC; Hernandez-Pampaloni M; Naeger DM
Acad Radiol; 2016 Sep; 23(9):1123-9. PubMed ID: 27283073
[TBL] [Abstract][Full Text] [Related]
17. Physician Assessment of Pretest Probability of Malignancy and Adherence With Guidelines for Pulmonary Nodule Evaluation.
Tanner NT; Porter A; Gould MK; Li XJ; Vachani A; Silvestri GA
Chest; 2017 Aug; 152(2):263-270. PubMed ID: 28115167
[TBL] [Abstract][Full Text] [Related]
18. Likelihood of malignancy in a solitary pulmonary nodule: comparison of Bayesian analysis and results of FDG-PET scan.
Dewan NA; Shehan CJ; Reeb SD; Gobar LS; Scott WJ; Ryschon K
Chest; 1997 Aug; 112(2):416-22. PubMed ID: 9266877
[TBL] [Abstract][Full Text] [Related]
19. Utility of FDG PET/CT for assessment of lung nodules identified during low dose computed tomography screening.
Hadique S; Jain P; Hadi Y; Baig A; Parker JE
BMC Med Imaging; 2020 Jun; 20(1):69. PubMed ID: 32571221
[TBL] [Abstract][Full Text] [Related]
20. Malignancy estimation of Lung-RADS criteria for subsolid nodules on CT: accuracy of low and high risk spectrum when using NLST nodules.
Chung K; Jacobs C; Scholten ET; Mets OM; Dekker I; Prokop M; van Ginneken B; Schaefer-Prokop CM
Eur Radiol; 2017 Nov; 27(11):4672-4679. PubMed ID: 28439653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
